publication date: Feb. 9, 2018

In Brief Arap, Pasqualini named to leadership posts at Rutgers Cancer Institute of New Jersey at University Hospital in Newark

Wadih Arap was named director of Rutgers Cancer Institute of New Jersey at University Hospital.

Previously, Arap served as chief of the Hematology/Oncology Division and deputy director of the University of New Mexico Comprehensive Cancer Center. Upon arrival to the Newark facility, Arap assumed the director role from Susan Goodin, professor of medicine at Rutgers Robert Wood Johnson Medical School, who served in an interim capacity.

Arap also will serve as chief in the Division of Hematology/Oncology in the Department of Medicine at Rutgers New Jersey Medical School.   

Since 2016, the multidisciplinary cancer service line at University Hospital in Newark has included care provided by Rutgers Cancer Institute medical and surgical oncologists augmenting radiation oncology services which have been provided there since 2009.

“Dr. Arap’s research and clinical expertise complements the mission of Rutgers Cancer Institute—the state’s only NCI-designated Comprehensive Cancer Center,” said Rutgers Cancer Institute Director Steven Libutti, who is also senior vice president of oncology services at RWJBarnabas Health and vice chancellor for cancer programs for Rutgers Biomedical and Health Sciences.

Adding to the leadership on the Newark campus, Renata Pasqualini was named chief of the Division of Cancer Biology in the Department of Radiation Oncology at Rutgers New Jersey Medical School. Prior to … Continue reading Arap, Pasqualini named to leadership posts at Rutgers Cancer Institute of New Jersey at University Hospital in Newark

To access this members-only content, please log in.
If you're not a subscriber why not join today?
If you believe you should be able to view this area but cannot log in, then please contact us and we will try to rectify this issue as soon as possible.
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.
Click here to join.

Copyright (c) 2018 The Cancer Letter Inc.